According to Omeros Corporation's latest financial reports the company's total assets are $0.49 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.59 B | 40.95% |
2021-12-31 | $0.41 B | 131.59% |
2020-12-31 | $0.18 B | 32.18% |
2019-12-31 | $0.13 B | 42.77% |
2018-12-31 | $95.93 M | -17.53% |
2017-12-31 | $0.11 B | 72.91% |
2016-12-31 | $67.27 M | 37.32% |
2015-12-31 | $48.99 M | 352.23% |
2014-12-31 | $10.83 M | -34.48% |
2013-12-31 | $16.53 M | -37.78% |
2012-12-31 | $26.57 M | -1.51% |
2011-12-31 | $26.98 M | -40.96% |
2010-12-31 | $45.7 M | -26.36% |
2009-12-31 | $62.06 M | 186.25% |
2008-12-31 | $21.68 M | -20.18% |
2007-12-31 | $27.16 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $171.96 B | 34,776.52% | ๐บ๐ธ USA |
Pfizer PFE | $226.50 B | 45,836.79% | ๐บ๐ธ USA |
Genetic Technologies GENE | $5.77 M | -98.83% | ๐ฆ๐บ Australia |
Eterna Therapeutics ERNA | $49.13 M | -90.04% | ๐บ๐ธ USA |